Biodexa Enters Into Agreements to Acquire Exclusive Worldwide License to Tolimidone, a Phase II Ready Asset for Type 1 Diabetes
November 27, 2023 09:00 ET
|
Biodexa Pharmaceuticals PLC
Cardiff , Nov. 27, 2023 (GLOBE NEWSWIRE) -- 27 November 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Agreements to Acquire Exclusive Worldwide License to...
SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California
November 21, 2023 09:30 ET
|
SOHM, Inc.
CHINO HILLS, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs...
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
November 15, 2023 02:00 ET
|
T-Therapeutics
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofinnova Partners, F-Prime Capital, Digitalis...
CARGO Therapeutics Announces Pricing of Initial Public Offering
November 09, 2023 20:07 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Announce Pricing of IPO
K36 Therapeutics Named “Overall BioPharma Startup of the Year” By BioTech Breakthrough
November 08, 2023 08:05 ET
|
BioTech Breakthrough
CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- K36 Therapeutics (“K36”) has been selected as “Overall BioPharma Startup of the Year” in the third annual BioTech Breakthrough Awards Program...
Garuda Therapeutics Named “Overall Cell Biology Company of the Year” By BioTech Breakthrough
November 08, 2023 08:03 ET
|
BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
BioTechnology Innovators Honored in 3rd Annual BioTech Breakthrough Awards Program
November 08, 2023 08:00 ET
|
BioTech Breakthrough
LOS ANGELES, Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
RS BioTherapeutics Promotes Michelle L. Shuffett, MD to Chief Medical Officer
October 31, 2023 11:00 ET
|
RS BioTherapeutics
RS BioTherapeutics is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.
Pruritus Therapeutics Market to Reach USD 12.6 Billion by 2032, Poised for Steady 4.1% CAGR
October 17, 2023 07:15 ET
|
MarketResearch.biz
New York, Oct. 17, 2023 (GLOBE NEWSWIRE) -- According to marketresearch.biz, the estimated size of the global pruritus therapeutics market in 2022 was USD 8.5 billion, and it is expected to exhibit...
ProPhase Labs to Present at The ThinkEquity Conference
October 12, 2023 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 12, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnostics company, today announced it will be...